Launched in 2023, Cryoviva Life Sciences, under the esteemed RJ Corp Group, stands as a multinational leader in advanced cryopreservation and cellular storage solutions. Its portfolio includes umbilical cord and cord blood banking, cord tissue, bone marrow and peripheral blood stem cell harvesting, and predictive genomics, services designed for both private and social banking. Each service is designed to preserve the miracle of life and safeguard the health of future generations.
An AABB-accredited company, Cryoviva Life Sciences is headquartered in Gurgaon and operates four state-of-the-art storage facilities equipped with technologies such as SEPAX for automated and precise cell processing. Supported by a compassionate and skilled scientific team, Cryoviva Life Sciences serves clients across 250+ cities in India and abroad, ensuring reliable and ethical care at every stage of the preservation journey.
Cryoviva Life Sciences provides end-to-end support covering collection, testing, processing, and long-term storage of stem cells. The organisation offers flexible packages tailored to diverse medical and financial needs, ensuring that every family has access to secure and reliable stem cell preservation.
Driven by a mission rooted in honesty, transparency, and commitment, Cryoviva Life Sciences aims to serve humanity through innovation, compassion, and excellence in regenerative medicine, truly standing as a bank of life for individuals globally.
